Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy

By Wilop Stefan   Hobe Sabine   Crysandt Martina   Esser Albert   Osieka Rainhardt   Jost Edgar  

Journal of Cancer Research and Clinical Oncology, Vol. 135, Iss. 10, 2009-10 ,pp. : 1429-1435

Springer Publishing Company

Access to resources Recommend Favorite

Potential Deployment of Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type 1 and Type 2 Receptor Blockers in Cancer Chemotherapy

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 6, Iss. 5, 2006-09 ,pp. : 451-460

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic effect of human umbilical cord mesenchymal stem cells modified by angiotensin-converting enzyme 2 gene on bleomycin-induced lung fibrosis injury

By        

Molecular Medicine Reports, Vol. 11, Iss. 4, 2015-01 ,pp. : 2387-2396

Spandidos Publications

Access to resources Recommend Favorite

Angiotensin converting enzyme inhibitors for cancer treatment?

By Lindberg Henriette   Nielsen Dorte   Jensen Benny   Eriksen Jens   Skovsgaard Torben  

Acta Oncologica, Vol. 43, Iss. 2, 2004-03 ,pp. : 142-152

Informa Healthcare

Access to resources Recommend Favorite

Endogenous hydrogen sulfide is associated with angiotensin II type 1 receptor in a rat model of carbon tetrachlorideinduced hepatic fibrosis

By          

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-01 ,pp. : 3351-3358

Spandidos Publications

Access to resources Recommend Favorite